Effects of rosuvastatin on coronary flow reserve and metabolic mismatch in patients with heart failure (from the CORONA study)

Abstract

Changes recarding myocardial perfusion and metabolic mismatch after 6 months of rosuvastatin treatment in patients with heart failure did not suggest any beneficial or adverse effects in this pilot study.

Keywords

• Rosuvastatin
• CORONA study
• coronary flow
• metabolic mismatch